Dr. Daniel Joseph Dammrich, MD

Dr. Dammrich practices at Northwestern Catherine Gratz Griffin Lake Forest Hospital in Lake Forest, Illinois.

Dr. Dammrich's NPI, 1417199670, was assigned on April 1, 2009. Dr. Dammrich graduated from Loyola University of Chicago, Stritch School of Medicine in 2006. Dr. Dammrich holds Illinois license 036145378.

Dr. Dammrich's primary practice is Northwestern Catherine Gratz Griffin Lake Forest Hospital, at 1000 N Westmoreland Rd, Lake Forest, IL 60045 in Lake County. The practice phone is (847) 234-5600.

Dr. Dammrich's primary practice is Northwestern Catherine Gratz Griffin Lake Forest Hospital in Lake Forest, Illinois. Dr. Dammrich is also affiliated with Northwestern Medicine Catherine Gratz Griffin Lake Forest Hospital. The medical group on file is Northwestern Medical Faculty Foundation. Dmand AI also links Dr. Dammrich to 3 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dammrich practices, 4 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Dammrich's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Dammrich's licenses on file in 2 states: Illinois and Florida.

CMS data shows 3,526 Medicare services from Dr. Dammrich across 16 procedure codes in 2024, for 696 Medicare patients. Medicare paid $237,528 for them.

CMS counts 696 Medicare patients who saw Dr. Dammrich in 2024. The largest group is 65 to 74, with 299 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 2.02, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Dammrich's median patient age at 73, with 56% women.

In 2024, Dr. Dammrich wrote 2,240 Medicare Part D claims for 407 patients. 73% of them were for generic drugs. CMS names the drug for 1,905 of them, across 45 drugs with 11 or more claims each, at $3,400,457 in total drug cost. In 2023, CMS named 1,399 claims across 39 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Dammrich for performance year 2024, reported through an alternative payment model (APM). Dr. Dammrich accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Dammrich as offering telehealth.

Dmand AI links 3 papers to Dr. Dammrich, published from 2011 to 2017. Dr. Dammrich's most frequent co-authors are Ikechukwu Immanuel Akunyili, MD, Juan Pablo Alderuccio, MD and Lauren Peirce Carcas, MD.

Dmand AI links Dr. Dammrich to 1 clinical trial. Conditions studied include Carcinoma, Non-Small-Cell Lung and Carcinoma, Bronchogenic.

CMS Open Payments shows 115 general payments to Dr. Dammrich from 21 drug and device companies from 2016 to 2024. Consulting fees make up the largest share, 61% of the total. Eli Lilly and Company paid the most, $3,473.

Dr. Dammrich graduated from Loyola University of Chicago, Stritch School of Medicine in 2006.